[DOI] [PubMed] [Google Scholar] 28.Newsome P.N., Ambery P
GLP-1-class compounds generally continue to drive loss out to 60-72 weeks before the curve flattens
The steady-state 24-hour urinary glucose excretion in patients with type 2 diabetes mellitus and mild, moderate, and severe renal impairment was 42%, 80%, and 90% lower, respectively, than in patients with type 2 diabetes mellitus with normal renal function
The starting dose of tirzepatide is 2.5 mg once a week, and after 4 weeks, the dose is increased to the therapeutic dose of 5 mg and administered subcutaneously in patients with T2D
Researchers should always cross-check reconstitution volume and storage requirements against their own study protocol, since exact figures vary by peptide and formulation
Liver Int (2013) 33(5):794804